The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127372101 12737210 1 I 20160907 20160913 20160913 EXP NL-JNJFOC-20160908007 JANSSEN ZOET ID, DE BOER NK, DE MEIJ TG. SUCCESSFUL VEDOLIZUMAB THERAPY IN A SIXTEEN-YEAR-OLD BOY WITH REFRACTORY ULCERATIVE COLITIS.. J CROHNS COLITIS 15-NOV-2015:373-374. 13.00 YR C M Y 0.00000 20160913 OT NL NL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127372101 12737210 1 PS INFLIXIMAB, RECOMBINANT INFLIXIMAB 1 Intravenous (not otherwise specified) Y N UNKNOWN 103772 LYOPHILIZED POWDER

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127372101 12737210 1 Colitis ulcerative

Outcome of event

Event ID CASEID OUTC COD
127372101 12737210 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127372101 12737210 Colitis
127372101 12737210 Drug ineffective

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found